These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 8036915)

  • 21. A novel hydrophobic omega-conotoxin blocks molluscan dihydropyridine-sensitive calcium channels.
    Fainzilber M; Lodder JC; van der Schors RC; Li KW; Yu Z; Burlingame AL; Geraerts WP; Kits KS
    Biochemistry; 1996 Jul; 35(26):8748-52. PubMed ID: 8679638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of Ca2+ concentration and Ca2+ channel blockers on noradrenaline release and purinergic neuroeffector transmission in rat tail artery.
    Brock JA; Cunnane TC
    Br J Pharmacol; 1999 Jan; 126(1):11-8. PubMed ID: 10051115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of presynaptic calcium channels with omega-conotoxin MVIIC and omega-grammotoxin SIA: role for a resistant calcium channel type in neurosecretion.
    Turner TJ; Lampe RA; Dunlap K
    Mol Pharmacol; 1995 Feb; 47(2):348-53. PubMed ID: 7870043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analgesic (omega)-conotoxins CVIE and CVIF selectively and voltage-dependently block recombinant and native N-type calcium channels.
    Berecki G; Motin L; Haythornthwaite A; Vink S; Bansal P; Drinkwater R; Wang CI; Moretta M; Lewis RJ; Alewood PF; Christie MJ; Adams DJ
    Mol Pharmacol; 2010 Feb; 77(2):139-48. PubMed ID: 19892914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mitochondrial dysfunction after experimental traumatic brain injury: combined efficacy of SNX-111 and U-101033E.
    Xiong Y; Peterson PL; Verweij BH; Vinas FC; Muizelaar JP; Lee CP
    J Neurotrauma; 1998 Jul; 15(7):531-44. PubMed ID: 9674556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tyr13 is essential for the activity of omega-conotoxin MVIIA and GVIA, specific N-type calcium channel blockers.
    Kim JI; Takahashi M; Ohtake A; Wakamiya A; Sato K
    Biochem Biophys Res Commun; 1995 Jan; 206(2):449-54. PubMed ID: 7826361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroprotective effects of SNX-185 in an in vitro model of TBI with a second insult.
    Shahlaie K; Gurkoff GG; Lyeth BG; Muizelaar JP; Berman RF
    Restor Neurol Neurosci; 2013; 31(2):141-53. PubMed ID: 23247061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential blockade of rat alpha3beta4 and alpha7 neuronal nicotinic receptors by omega-conotoxin MVIIC, omega-conotoxin GVIA and diltiazem.
    Herrero CJ; García-Palomero E; Pintado AJ; García AG; Montiel C
    Br J Pharmacol; 1999 Jul; 127(6):1375-87. PubMed ID: 10455287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of continuous intrathecal infusion of omega-conopeptides, N-type calcium-channel blockers, on behavior and antinociception in the formalin and hot-plate tests in rats.
    Malmberg AB; Yaksh TL
    Pain; 1995 Jan; 60(1):83-90. PubMed ID: 7715945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of calcium channels that control neurosecretion.
    Dunlap K; Luebke JI; Turner TJ
    Science; 1994 Nov; 266(5186):828-31. PubMed ID: 7973643
    [No Abstract]   [Full Text] [Related]  

  • 31. Calcium channel subtypes in rat brain: biochemical characterization of the high-affinity receptors for omega-conopeptides SNX-230 (synthetic MVIIC), SNX-183 (SVIB), and SNX-111 (MVIIA).
    Woppmann A; Ramachandran J; Miljanich GP
    Mol Cell Neurosci; 1994 Aug; 5(4):350-7. PubMed ID: 7804605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of isradipine, an L-type calcium channel blocker on permanent and transient focal cerebral ischemia in spontaneously hypertensive rats.
    Campbell CA; Mackay KB; Patel S; King PD; Stretton JL; Hadingham SJ; Hamilton TC
    Exp Neurol; 1997 Nov; 148(1):45-50. PubMed ID: 9398449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of non-L-type calcium channel antagonists on phencyclidine-induced effects in rats.
    Popoli P; Pèzzola A; Scotti de Carolis A
    Life Sci; 1993; 52(25):2055-61. PubMed ID: 8502132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potentiation of aspirin-induced cerebroprotection by minocycline: a therapeutic approach to attenuate exacerbation of transient focal cerebral ischaemia.
    Bhatt LK; Addepalli V
    Diab Vasc Dis Res; 2012 Jan; 9(1):25-34. PubMed ID: 22045867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Post-treatment of transient focal cerebral ischemia in rats with the novel cerebrovascular-selective Ca2+ channel antagonist (+/-)-(E)-1-(3-fluoro-6,11-dihydrodibenz[b,e]-oxepine-11-yl)-4-(3-pheny l-2-propenyl)-piperazine dimaleate.
    Minato H; Kikuta C; Masuda Y; Fujitani B; Hosoki K
    Arzneimittelforschung; 1997 Jul; 47(7):799-802. PubMed ID: 9272234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuropeptide Y and calcitonin gene-related peptide modulate voltage-gated Ca2+ channels in mature female rat paracervical ganglion neurons.
    Cohen DP; Ikeda SR; Lewis DL
    J Soc Gynecol Investig; 1996; 3(6):342-9. PubMed ID: 8923419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of voltage-dependent calcium channel subtypes in experimental tactile allodynia.
    Chaplan SR; Pogrel JW; Yaksh TL
    J Pharmacol Exp Ther; 1994 Jun; 269(3):1117-23. PubMed ID: 8014856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroprotection in the rat lateral fluid percussion model of traumatic brain injury by SNX-185, an N-type voltage-gated calcium channel blocker.
    Lee LL; Galo E; Lyeth BG; Muizelaar JP; Berman RF
    Exp Neurol; 2004 Nov; 190(1):70-8. PubMed ID: 15473981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Can ziconotide as a N-type voltage-sensitive calcium channel blocker open a new mode for treatment of autism? A hypothesis.
    Ghanizadeh A
    Neurosciences (Riyadh); 2011 Jan; 16(1):83. PubMed ID: 21206454
    [No Abstract]   [Full Text] [Related]  

  • 40. Neurex launches phase III program for SNX-111 for the treatment of chronic pain.
    AIDS Patient Care STDS; 1996 Oct; 10(5):311-2. PubMed ID: 11361532
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.